Skip to content
Preprint · CC-BY via bioRxiv

Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies

Lu, X., Hayashi, H., Ishikawa, E., Takeuchi, Y., Dychiao, J. V. T., Nakagami, H., Yamasaki, S.

biorxiv · 2024

Abstract

SARS-CoV-2 vaccines have been used worldwide to combat COVID-19 pandemic. To elucidate the factors that determine the longevity of spike (S)-specific antibodies, we traced the characteristics of S-specific T cell clonotypes together with their epitopes and anti-S antibody titers before and after BNT162b2 vaccination over time. T cell receptor (TCR) {beta} sequences and mRNA expression of the S-responded T cells were investigated using single-cell TCR- and RNA-sequencing. Highly expanded 199 TCR clonotypes upon stimulation with S peptide pools were reconstituted into a reporter T cell line for the determination of epitopes and restricting HLAs. Among them, we could determine 78 S epitopes, most of which were conserved in variants of concern (VOCs). After the 2nd vaccination, T cell clonotypes highly responsive to recall S stimulation were polarized to follicular helper T (Tfh)-like cells in donors exhibiting sustained anti-S antibody titers (designated as "sustainers"), but not in "decliners". Even before vaccination, S-reactive CD4+ T cell clonotypes did exist, most of which cross-reacted with environmental or symbiotic bacteria. However, these clonotypes contracted after vaccination. Conversely, S-reactive clonotypes dominated after vaccination were undetectable in pre-vaccinated T cell pool, suggesting that highly-responding S-reactive T cells were established by vaccination from rare clonotypes. These results suggest that de novo acquisition of memory Tfh-like cells upon vaccination may contribute to the longevity of anti-S antibody titers.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
bioRxiv
DOI
10.1101/2023.06.06.543529
Canonical
link ↗
Fetched
2026-10-11 MST

Cite this

APA
X., L., H., H., E., I., Y., T., T., D.J.V., H., N., &amp; S., Y. (2024). Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies. <em>biorxiv</em>. https://doi.org/10.1101/2023.06.06.543529
Vancouver
X. L, H. H, E. I, Y. T, T. DJV, H. N, et al. Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies. biorxiv. 2024. doi:10.1101/2023.06.06.543529.
BibTeX
@unpublished{lu2024Earlya, title = {Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies}, author = {Lu, X. and Hayashi, H. and Ishikawa, E. and Takeuchi, Y. and Dychiao, J. V. T. and Nakagami, H. and Yamasaki, S.}, journal = {biorxiv}, year = {2024}, doi = {10.1101/2023.06.06.543529}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings